Results 81 to 90 of about 42,805 (221)

CA125: Holy Grail or a Poisoned Chalice [PDF]

Nephron Clinical Practice, 2005
The history of (and perhaps the lessons to be learned from) peritoneal CA125 investigation presents no better example of the diffi culties in assigning the status of a ‘marker’ predictive of membrane dysfunction to factors measured in dialysis effl uent. In 1995, Visser et al. [3] were the fi rst to suggest that CA125 could be used as ‘a bulk marker of
Nicholas, Topley, Daryn, Michael, Timothy, Bowen   +2 more
openaire   +2 more sources

Integrating Clinical Features, Laboratory Biomarkers and Computed Tomography for the Discrimination of Non‐Small Cell Lung Cancer and Benign Pulmonary Diseases: A Clinical Prediction Model

Journal of Clinical Laboratory Analysis, EarlyView.
This study developed and validated a clinical prediction model to differentiate non‐small cell lung cancer (NSCLC) from benign pulmonary diseases using clinical features, laboratory biomarkers, and CT features. The model achieved an AUC‐ROC of 0.95 in the training set and 0.82 in the validation set, demonstrating reliable diagnostic performance and ...
Jie Zhang, Shui Liu, Mingjian Bai, Fucun Ma, Guowei Liang, Bing Wang   +5 more
wiley   +1 more source

Distinguishing lung cancer from atypical tuberculosis: Deep transfer learning and imaging omics features

Journal of Intelligent Medicine, EarlyView.
The 3D‐ResNet model demonstrates superior discriminative power in differentiating lung cancer from atypical tuberculosis by leveraging deep omics features derived from volumetric lung cancer imaging, outperforming conventional clinical and radiomic analyses.
Yi Wu, Siyi Li, Zhiping Long, Yanjie Jia, Yue Yu, Bing Pei, Heli Yuan, Yuhua Hao, Zhiyun Jiang, Lei Cao, Kezheng Wang, Fan Wang   +11 more
wiley   +1 more source

Akurasi Kadar Lysophosphatidic Acid Plasma dan Ca125 Serum Penderita Tumor Ovarium Jenis Epitel untuk Prediktor Keganasan Ovarium

Indonesian Journal of Cancer, 2014
This study was conducted to determine and compare the sensitivity, specificity, positive predictive value and negative predictive value between CA125, Lysophosphatidic Acid Plasma (LPA) and combination of LPA - CA125 in patients with ovarian mass ...
TRI APRILIAWAN, BRAHMANA ASKANDAR
doaj   +1 more source

Screening for gynecological cancers [PDF]

, 2016
An estimated 17% of all new cancers in women worldwide are due to cancers of the cervix, the ovary and the uterus. Together, these cancers account for 14.6% of all female cancer deaths.
Kalsi, JK, Manchanda, R, Menon, U
core   +1 more source

Exploring the impact of microbial dysbiosis on ovarian cancer and the therapeutic potential of probiotics

VIEW, EarlyView.
Ovarian cancer has been linked to the microbiome as a potential environmental contributor, but how this association relates to tumor progression remains unclear. By comparing tumor and nontumor tissues, we identified a severity‐associated microbial and metabolic signature and showed that probiotics can partially restore immune balance and slow tumor ...
Chanyuan Li, Nalan Tu, Xin Ning, Yunyan Cong, Fei Wu, Xiuli Zhang, Runrong Li, Yue Xu, Binqiao Wang, Liqin Jin, Yuanming Shen, Jihong Liu   +11 more
wiley   +1 more source

Struma Ovarii Associated with Ascites and Elevated CA125: Two Case Reports and Review of the Literature

International Journal of Women's Health, 2022
Shaoyu Wang, Xinqin He, Huijuan Yang, Lihong Chen Department of Obstetrics and Gynecology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, People’s Republic of ChinaCorrespondence: Lihong Chen, Department of Obstetrics and ...
Wang S, He X, Yang H, Chen L
doaj  

Change-point of multiple biomarkers in women with ovarian cancer [PDF]

, 2017
To date several algorithms for longitudinal analysis of ovarian cancer biomarkers have been proposed in the literature. An issue of specific interest is to determine whether the baseline level of a biomarker changes significantly at some time instant ...
Blyuss, O, Dawnay, A, Gentry-Maharaj, A, Jacobs, I, Kalsi, J, Mariño, IP, Menon, U, Ryan, A, Timms, JF, Zaikin, A   +9 more
core   +1 more source

Analysis of Peripheral T Cell Profiling and Plasma Proteomics in Advanced NSCLC Patients Treated With Atezolizumab

Cancer Science, EarlyView.
This study found immune markers that may predict how well patients with advanced lung cancer respond to atezolizumab. Higher levels of certain T cells were linked to better survival. Specific patterns suggested a worse prognosis for some patients. ABSTRACT We investigated immunologic biomarkers that predict outcomes of patients with previously treated ...
Atsuto Mouri, Hiroshi Kagamu, Koji Tamada, Makoto Nishio, Hiroaki Akamatsu, Yasushi Goto, Hidetoshi Hayashi, Satoru Miura, Akihiko Gemma, Ichiro Yoshino, Toshihiro Misumi, Ryota Saito, Noriko Yanagitani, Fujita Masaki, Hiroshi Nokihara, Kazumi Nishino, Masahiro Seike, Tetsunari Hase, Osamu Hataji, Hiroaki Takeoka, Yosuke Kawashima, Hirotaka Kuroki, Masamichi Sugimoto, Hiroshi Kuriki, Tetsuya Mitsudomi   +24 more
wiley   +1 more source

Biochemical markers in cancer of the ovary : a review [PDF]

, 1990
The ideal tumour marker would be one which is detectable before obvious clinical involvement. A number of biochemical markers have been used to diagnose carcinoma of the ovary.
Cauchi, Maurice N.
core